TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ABVX

Abivax S.A.

Healthcare · Biotechnology

94.90$ +0.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABVX
Line item Q3 22 Q4 22 Q1 23 Q2 23 Q4 23 Q2 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
– 100.0% – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 47.9% – 76.2% 87.4% 85.4% 83.2% 79.5% 72.0% 95.0% 95.0% 93.8%
– 35.7% – 66.9% 77.0% 78.1% 70.3% 62.0% 50.9% 90.4% 79.2% 87.3%
– 35.7% – 66.9% 79.8% 78.1% 70.3% – 50.9% – 81.3% –
– 11.0% – 7.4% 5.8% 6.2% 7.6% – 12.3% – 1.6% –
– 16.1% – 1.8% -1.8% – – – – – – –
– 2.1% – 0.8% – – – – – – – –
– 24.4% – 10.8% 5.6% 6.5% 9.0% 11.0% 15.4% 2.8% 2.8% 3.4%
– 8.7% – 3.9% 2.0% 2.3% 3.2% 4.0% 5.5% 1.0% 1.0% 1.2%
– 90.5% – 53.0% 40.1% 55.5% 80.2% 103.9% 140.4% 21.6% 21.6% 21.5%
– 68.1% – 27.0% 26.9% 28.1% 45.2% 63.3% 93.9% 12.1% 12.1% 11.4%
– 39.8% – 5.6% 9.6% 13.4% 21.3% – 40.8% – 4.5% –
– 20.5% – 8.9% 14.4% 10.7% 21.4% 33.9% 30.2% 2.2% 5.8% 1.8%
– 48.4% – 14.3% 13.7% – 25.4% 28.2% 29.1% 2.4% – –
– 9.5% – 47.0% 59.9% 44.5% 19.8% -3.9% -40.4% 78.4% 69.8% 78.5%
– -190.0% – -30.4% -86.5% -124.1% -213.8% -291.4% -441.8% -102.7% -113.2% -139.7%
– 29.5% – 21.0% 14.8% 22.1% 30.8% 38.0% 53.0% 11.9% 10.7% 14.5%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?